The Sanofi logo on the walls of the company's headquarters in Paris.


Thibault Camus / AP / SIPA

The management of Sanofi-Aventis Research and Development (R&D) specified Thursday, during a central social and economic committee (CSE), that it wanted to cut 364 jobs, "mainly in research", and transfer to the Paris region the 56 posts of its Strasbourg site, we learned from union sources.

As part of a restructuring announced in June 2020

The job cuts will be carried out via a job protection plan (PSE) including a voluntary departure plan (PDV), according to these union sources.

They are part of the restructuring announced in June 2020 by the pharmaceutical group Sanofi.

The laboratory then said it wanted to cut up to 1,700 jobs in Europe, including a thousand in France.

  • Abolition of posts

  • Pharmaceutical industry

  • Employment

  • Sanofi

  • Economy